| Description |
Rosuvastatin sodium salt-[d3] is a labelled impurity of Rosuvastatin. Rosuvastatin, also called as ZD 4522 or Crestor, a synthetic statin, in the phase III HYDRA trial for Hypercholesterolaemia, is a competitive inhibitor of HMG-CoA reductase (IC50 = 11 nM). |
| Synonyms |
(3R,5S,6E)-7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl-d3)amino]-5-pyrimidinyl]-3,5-dihydroxy-6-heptenoic Acid Monosodium Salt; [S-[R*,S*-(E)]]-7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl-d3)amino]-5-pyrimidinyl]-3,5-dihydroxy-6-heptenoic Acid Monosodium Salt; (3R,5S,6E)-7-[4-(4-Fluorophenyl)-6-isopropyl-2-[(methanesulfonyl-d3)methylamino]pyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic Acid Sodium Salt |
| IUPAC Name |
sodium;(E,3R,5S)-7-[4-(4-fluorophenyl)-2-[methylsulfonyl(trideuteriomethyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoate |
| Related CAS |
147098-18-8 (unlabelled)
|
| Canonical SMILES |
CC(C)C1=NC(=NC(=C1C=CC(CC(CC(=O)[O-])O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C.[Na+] |
| InChI |
InChI=1S/C22H28FN3O6S.Na/c1-13(2)20-18(10-9-16(27)11-17(28)12-19(29)30)21(14-5-7-15(23)8-6-14)25-22(24-20)26(3)33(4,31)32;/h5-10,13,16-17,27-28H,11-12H2,1-4H3,(H,29,30);/q;+1/p-1/b10-9+;/t16-,17-;/m1./s1/i3D3; |
| InChI Key |
RGEBGDYYHAFODH-SYRJKFITSA-M |
| Melting Point |
>104°C(dec.) |
| Purity |
≥90% |
| Solubility |
Soluble in DMSO |
| Appearance |
Off-white to Pale Yellow Solid |
| Storage |
Store at-20°C |
![Rosuvastatin sodium salt-[d3]](/isotope.v1/images/structure-default.jpg)
